ArticleFrontiers in surgery2026
Prognosis of renal re-transplantation for chronic graft failure.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the clinical characteristics, patient survival rate, and graft survival rate differences between renal re-transplantation recipients (ReTR) and first-time recipients (FTR) of matched donor kidneys by comparing clinical data, providing evidence for improving graft survival rates in re-transplantation patients. Methods: A retrospective analysis was conducted on renal transplant patients from the Organ Transplant Center of the Northern Theater Command General Hospital between 2020 and 2024. The patients were divided into two groups: the recipient group (ReTR) who received a second kidney transplant and the first recipient group (FTR) who received a matched donor kidney. Clinical data from both groups were collected, and postoperative follow-up was performed. Results: The group of recipients undergoing renal re-transplantation and the group of initial recipients with matched donor kidneys were each 24 cases. Compared with the initial recipients with matched donor kidneys, the recipients of renal re-transplantation exhibited higher positive rate of population reactive antibodies (PRA) ( Conclusions: The graft survival period in patients undergoing repeat renal transplantation is lower than that in first-time renal transplantation, but there is no significant difference in overall survival. Attention should be paid to prevention of postoperative DGF occurrence.Other clinical indicators such as platelet changes, and patients nutritional status should be improved, with a low-purine diet as the mainstay, and uric acid-lowering drugs should be used when necessary.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.